tirzepatide and cymbalta FDA approves generics of Lilly antidepressant Cymbalta for Depression Treatment: A

The drug manufacturer does not want the public or their competitors to know the rebate that they offered. Gray said

These developments underscore the regulatory challenges facing telehealth companies attempting to capitalize on the growing demand for GLP-1-based treatments, which include both weight loss and diabetes management therapies

Having read this recent article in the Daily Mail its becoming apparent that Ozempic is something to be considered with absolute caution

Carbonated Beverages: Sodas and sparkling waters introduce trapped gas

Nature 586 , 567571 (2020)

Are there any safer or less expensive alternatives to GLP-1s for weight loss and glucose-lowering